<DOC>
	<DOCNO>NCT00510900</DOCNO>
	<brief_summary>The propose work seek understand effect LAA occlusion cardiac structure function , homeostasis . Numerous study implicate leave atrial appendage ( LAA ) source vast majority leave atrial thrombus set AF3 . The University Pittsburgh Medical Center implant Left Atrial Appendage filter system ( WATCHMAN® Left Atrial Appendage Filter System , manufacture Atritech , Inc. ) . We aim follow patient six month post implant order assess heart rhythm , function , blood test evaluate neurohormonal change .</brief_summary>
	<brief_title>Effects Left Atrial Appendage Occlusion</brief_title>
	<detailed_description>Atrial fibrillation ( AF ) , heart rhythm disorder , major health problem . As many 3 million US person afflict ; number expect rise significantly come decade AF incidence directly correlate age1 . AF significantly associate cardiovascular morbidity mortality . The University Pittsburgh Medical Center implant Left Atrial Appendage filter system ( WATCHMAN® Left Atrial Appendage Filter System , manufacture Atritech , Inc. ) . We aim follow patient six month post implant order ass : 1 . Blood test monitor biochemical marker cardiac remodel index heart function . We assess atrial natriuretic factor ; brain natriuretic peptide ; norepinephrine ; matrix metalloproteinases 1 , 2 , 3 , 8 , 9 , 13 ; gelatinases 2 9 ; soluble tumor necrotic factor-II ; angiotensin ; aldosterone ; ADH ; rennin ; interleukin-6 ; TNF-α ; homocysteine ; C-reactive protein ; quantitative D-dimer ; fibrin ; fibrinogen ; fibrin split product . Biochemical marker cardiac remodel intensively study globally , novel marker discover publish frequently . Serum bank duration study allow retrospective investigation newly publish marker . 2 . Echocardiogram evaluate myocardial function atrial work . 3 . 24 hour holter monitor evaluate subject ' heart rhythm presence absence atrial fibrillation . This study non-blinded observational study control group . Subjects recruit patient pool Principal Investigator Co-Investigators . All subject intervention group WATCHMAN device implant UPMC . The control group trial comprise age-matched control control group WATCHMAN device trial , also patient pool Principal Investigator Co-Investigators . Subjects approach one Investigators . The primary outcome interest leave atrial work , measure continuous scale . Analysis covariance ( ANCOVA ) use compare mean leave atrial work score 12 month intervention non-intervention patient group adjust baseline value .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>18 year age old Ability give inform consent . Patient enrol WATCHMAN device trial UPMC . 4 Documented history atrial fibrillation . Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>